Niraparib: Phase I/II data

Data from 11 evaluable patients with platinum-sensitive, high-grade serous or endometrioid ovarian cancer in the open-label, Danish Phase

Read the full 189 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE